Sign in
4

Changes in Ownership

Cardiff Oncology, Inc. Filed Acc 0001628280-21-012169

Options or other derivatives

  • Former Director acquired 473,468 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
ADAMS THOMAS PHD Former Director 2021-06-10 Other acquisition · Stock Options +272 477,870 D
ADAMS THOMAS PHD Former Director 2021-06-10 Other acquisition · Stock Options +223 477,870 D
ADAMS THOMAS PHD Former Director 2021-06-10 Other acquisition · Stock Options +223 477,870 D
ADAMS THOMAS PHD Former Director 2021-06-10 Other acquisition · Stock Options +530 477,870 D
ADAMS THOMAS PHD Former Director 2021-06-10 Other acquisition · Stock Options +755 477,870 D
ADAMS THOMAS PHD Former Director 2021-06-10 Other acquisition · Stock Options +298,320 477,870 D
ADAMS THOMAS PHD Former Director 2021-06-10 Other acquisition · Stock Options +173,145 477,870 D
Loading xslF345X03/wf-form4_162370142446711.xml…